Health

CAMHS/CYPS, Clinical Activity Data, Health

Please could you provide me with the key learning themes and recommendations identified from care reviews relating to deaths by suicide, where individuals were open to the Crisis Team within Gloucestershire at the time of death.
In addition, could you please provide evidence of how these recommendations have been implemented into policy and practice during the following periods:

• January 2024 – January 2025
• January 2025 – present day

Paediatric Elective Care (RTT)

Under the Freedom of Information Act 2000 I would like to request the following information.

Please provide two sets of waiting list data on paediatric elective care (RTT) (patients aged 0–17) for your Trust, disaggregated by:

1. Ethnicity (using NHS standard ethnicity categories), and
2. Indices of Multiple Deprivation (IMD) deciles or quintiles (based on patient postcode or other available proxy).

For each combination of ethnicity and IMD group, please provide the number of patients waiting in each of the following time bands:

1. Up to 18 weeks
2. 18 to 26 weeks
3. 26 to 40 weeks
4. 40 to 52 weeks
5. 52 weeks and over

Please provide this data monthly, from September 2021 to September 2025 (or the most recent available month), with each month reported separately.

If providing both ethnicity and IMD breakdowns would exceed the cost, please prioritise the ethnicity breakdown.

Please provide the data in spreadsheet format (e.g., Excel or CSV).

Spinal Muscular Atrophy (SMA) Treatment

Clinical Activity Data, Health

I would be grateful if you could please answer the following questions with regards to treatment of spinal muscular atrophy:

1. Within your Trust/ Health Board, where are patients (aged 2yrs +) with a diagnosis of Spinal Muscular Atrophy referred to for treatment?

2. How many patients with Spinal Muscular Atrophy have been referred in:

A. The last 12 months? (or the latest 12 months of data you have available)
B. The last 5 years?

Could you please split this out into SMA type if possible ( Type 0, 1, 2, 3, 4) – (see attached ICD-10 codes)

3. If your Trust/ Health Board receives referrals, where are these referrals made from?

4. How many patients return to local care for continued treatment once referred to a specialist centre?

5. If you have a treating centre for Spinal Muscular Atrophy in your trust, what is the average length of stay (or annual bed days) of patients being treated?

If you are unable to answer all of these questions, please provide answers to those that are possible to answer. Thank you for taking the time to look into this request.

CAAAS Waiting Lists

CAMHS/CYPS, Health, MH Services

Please can you answer the following (I have already FOI’d and I am happy to include this in the next FOI).

1. How are the waiting times for the CAAAS shared within the organisation?

2. What is the governance process from team to Board to ensure the Board is sighted on this issue?

3. I note your Trust risk register as reported in latest board figures is quite generic.

a. Is the CAAAS waiting list issue on the risk register?
b. What is it scored and what are the mitigating actions?

4. There was limited mention of CAAAS in any of your 2025 Board Papers (this links to my point above). There was a quote from a NED at the Go and See in May Board papers ‘the waiting list is impacted by several factors including the amalgamation of others’ waiting lists into CAAAS’.

a. What is the material impact?
b. What is the nature of the problem?
c. How is the service mitigating the impact?

5. How are you assuring yourself around actual or potential harm relating to the extremely extended waits in CAAAS?

6. Further to above if the waiting list is growing what is the organisation doing regarding mutual aid or outsourcing?

Community Mental Health Access

This Freedom of Information request question is for your Community Mental Health Teams in your area (i.e. NOT your Early Intervention in Psychosis team; Crisis Resolution or Home treatment team; or Rehabilitation and Recovery team or Assertive Outreach team).

Please can you provide information on the below questions in relation to the following case example.

A 35-year-old person with severe OCD and BDD has been assessed by your local Talking Therapies service as being too complex and inappropriate for them. They are severely impaired, virtually housebound, have no social life and unable to work. Their basic needs are provided by the family, but the family is struggling to support them. They are not an immediate risk of suicide, self-harm or violence to others and do not need admission to an acute ward. They are not personality disordered. The GP has already followed the NICE guidelines for OCD/BDD, and the patient has had 2 trials of SSRIs at maximum dose for at least 4 months each with little benefit. The patient and their family are seeking an assessment by a consultant psychiatrist and cognitive behaviour therapy with exposure and response prevention which is specific for OCD/BDD.

1. How long approximately is the wait list (e.g. number of weeks) to obtain an assessment by the CMHT and would this be by a consultant psychiatrist or their specialist trainee?
2. Are there criteria used to accept a rereferral onto your Community Mental Health Teams to have a care co-ordinator and provide treatment? If you have criteria, please can you supply them?
3. How long approximately is the wait list to obtain (a) a psychological assessment and then (b) how long is wait for CBT for OCD/BDD in secondary care (e.g. number of weeks)?
4. What is the documented or expected care pathway (e.g. do they have to be seen first by the CMHT and then referred by the CMHT for secondary care psychological therapies or can the referral be done directly by the Talking Therapies or GP for example)?
5. Do your policies or procedures indicate that any alternatives offered to CBT with ERP, for people in the above scenario, e.g. a different type of psychological therapy?
6. Has your team made a referral to tertiary services for OCD/BDD in the last 5 years a) under the Highly Specialised Service stream of funding or b) under local funding?

Monitoring Technology used in Patient Bedrooms

Contracts, Estates, Health, MH Services, Safety and Security

Dear Gloucestershire Health and Care NHS Foundation Trust,

I am writing to request the following information under the Freedom of Information Act.

1. Please confirm, does the Trust use, or have plans to use, Oxevision* in ward bedrooms, 136 suites and/or seclusion rooms?

*Please note that Oxevision may be referred to by other names including LIO or ‘vision-based monitoring technology’ etc. It is an infrared camera system.

2. Please confirm, does that Trust use, or have plans to use, ‘Project X’^ in ward bedrooms, 136 suites and/or seclusion rooms.

^Please note that Project X may be referred to by different names, for the avoidance of doubt it is marketed by Safehinge Primera and may be described as a ‘non-visual patient safety aid’ and uses radar to track patients’ movements.

3. Please outline whether the trust uses any other video, camera or vision-based patient monitoring systems within patient bedrooms. Please state brand names if appropriate.

4. If the response to any of the above questions is ‘yes’, please provide the following information:

4.1. Please confirm the number of wards/136 suites/seclusion rooms, and provide ward names, where Oxevision/Project X/other vision based monitoring technologies is currently used.

4.2. Please provide your policy or standard operating procedure for the use of Oxevision/Project X/other vision based monitoring technologies, up to the date and time of this request.

4.3. Please provide your Data Protection Impact assessment for the use of Oxevision/Project X/other vision based monitoring technologies.

4.4. Please provide an Equality Impact Assessment in relation to the use of Oxevision/Project X/other vision based monitoring technologies

4.5. Please state the contract end date(s) for all current contract(s) with Oxehealth/LIO health/other organisations that provide the above technologies..

4.6. Please provide patient posters, leaflets and/or information packs.

Cardiology Software and Vendor Neutral Archive Systems

GHNHSFT - Redirect, Health, IT

Good morning,
I am writing to request information under the Freedom of Information Act 2000.

Please could you provide the following details regarding your Trust’s use of digital systems in the cardiology department:

1. Does your Trust currently use any software systems to manage clinical records, diagnostics, or workflows within cardiology?

2. If yes, please provide:

a The name of the software provider and product.
b The start date and duration of the current contract.
c The expiry date or next renewal date of the contract.
d Whether the contract includes options for extension or renewal.

Additionally:

3. Does your Trust currently use a Vendor Neutral Archive (VNA) system to store and manage medical imaging or other clinical data across departments?

4. If yes, please provide:

a The name of the VNA provider and product.
b The departments where it is currently deployed.
c The start date, duration, and expiry/renewal date of the contract.
d Whether the contract includes options for extension or renewal.

I would prefer to receive the information electronically, if possible. I understand that under the Act, you are required to respond to this request within 20 working days. If any of the requested information is exempt from disclosure, please specify the exemption and provide any non-exempt information that can be released.

Thank you for your assistance.

Designing safe spaces for patients at high risk of infection

To: Infection Control Teams Dear Colleagues,

We are carrying out a short 10 question survey to understand how NHS Trusts are implementing the guidance from NHS Estates Technical Bulletin 2024/3: Designing safe spaces for patients at high risk of infection from nontuberculous mycobacteria (NTM) and other waterborne pathogens.

This survey is being carried out to gain insight into how the recommendations of the bulletin have informed local water safety practice and capital planning across NHS organisations; and to identify common challenges in water safety management across healthcare settings.

A summary of anonymised findings will be shared with participating Trusts on request.

Under the Freedom of Information Act 2000, we seek the following information within your NHS Trust / NHS Foundation Trust:

1. Name of NHS Trust/Foundation Trust:

2. Has your organisation reviewed NHS Estates Technical Bulletin 2024/3 with the specific note on non-tuberculous mycobacteria?

Yes
No

3. Does your organisation treat any of the “high-risk” patient groups listed in the NHS Estates Technical Bulletin 2024/3? Tick all that apply

Lung and/or heart transplant
Cystic fibrosis
Haematology/oncology patients with neutropenia,
CAR-T cell patients
Other solid organ transplant,
Patients with long-term lines

4. Do you have a Water Safety Group or equivalent multidisciplinary body for any water-related issues?

Yes
No

5. Do you currently conduct routine environmental water testing for NTM? If yes, please state the areas tested and the frequency of testing.

Yes
No

Areas tested (type here):

Frequency (type here):

6. Does your Water Safety Plan include specific controls for NTM, separate from general Legionella/Pseudomonas measures? – If yes, please specify.

Yes
No

Specify (Type here):

7. If NTM testing is undertaken, which laboratory/method is used, and is it UKAS-accredited to ISO 17025 for NTM testing or according to the methods suggested in the bulletin?

N/A (have not tested for NTM)

If testing, which laboratory/method is used? (type here):

Is testing method accredited (type here):

8. If you have tested, have you detected NTM in water samples from patient care areas in the last 3 years? (Yes/No; if yes, please indicate the area(s) and summarise the control measures taken).

Yes
No

N/A (have not tested for NTM)

Specify areas (type here):

Summarise control measures (type here):

9. Which control and/or remedial measures are you currently using to manage waterborne pathogens in your organisation? Tick all that apply

Point-of-use filters
Temperature controls
Chemical controls (any, i.e. chlorine, silver-copper ionization)
Pipe removal work (including new copper pipes)
Descaling and cleaning of water outlets
Complete removal of outlets/sink
Other (please list below)

Other (type here):

10. In the last 5 years, have you made any design changes in high-risk areas specifically to reduce waterborne infection risk (e.g., removal or relocation of sinks, drainage modifications, point-of-entry filtration)? (Yes/No; please provide brief examples).

Yes
No

11. Are you planning any major refurbishment in the next 5 years and/or is your organization part of the NHS New Hospital Programme? (Tick all that apply)

Yes – planning refurbishment works
Yes – part of the NHS New Hospital Programme
No – neither

Electroconvulsive Therapy (ECT) 2024

Corporate Governance, Health

Good evening,

This is a request under the Freedom of Information Act 2000.

Please provide the following information relating to your Trust’s use of electro-convulsive therapy for the period between 1 January 2024, to 31 December 2024:

Treatments delivered by consent status, specifically including the number of treatments given to a) those incapable of consenting, but ECT authorised where patient resists or objects (under Mental Health Act Section 58A), and b) those incapable of consenting, but ECT authorised where a patient does not resist or object (under Mental Health Act Section 58A).

If information with this distinction is unavailable, please simply provide it for the number of treatments where a patient did not consent.

Please confirm the number of patients this pertains to for this period.

Please also separate this information out by age, gender, and IMD decile (or if not possible, quintile).

Patient Notes — Paper and Electronic

I would like to request the following information under the Freedom of Information Act.

Question 1:
– Are PATIENT NOTES* in your trust: all paper, all electronic, or a mixture of both?
– If patient notes are primarily electronic:
– When did the trust transition from paper to electronic?
– What is the name of the electronic patient record platform used?
– If patient notes are primarily paper:
– Are there plans to transition from paper to electronic? If yes, when?
* ‘Patient notes’ here refers to written documentation of clinical encounters with patients, completed by a healthcare professional.

Question 2:
– Are DRUG CHARTS in your trust all paper, all electronic, or a mixture of both?
– If drug charts are primarily electronic:
– When did the trust transition from paper to electronic?
– What is the name of the electronic prescribing system used?
– If drug charts are primarily paper:
– Are there plans to transition from paper to electronic? If yes, when?

Question 3:
– Do the following departments in your trust use paper PATIENT NOTES (either partially or fully)? Please indicate Yes, No or Not sure / Not applicable.
– Inpatient wards
– Outpatients

Question 4:
– Do the following departments in your trust use paper DRUG CHARTS (either partially or fully)? Please indicate Yes, No or Not sure / Not applicable.
– Inpatient wards
– Outpatients

Question 5:
– Are fax machines still used in any part of your trust? (Yes / No)

If you have any queries, please don’t hesitate to contact me on ssantospaulo@bmj.com

Continence and Stoma Care agreement(s) for nurse sponsorship

I am writing to you under the Freedom of Information Act 2000 to request the following
information from Gloucestershire Health and Care NHS Trust relating to Continence and Stoma
Care agreement(s) for nurse sponsorship.
1. Do you have Continence and/or Stoma sponsorship agreement (or agreements) in place
across your Trusts’ different hospital sites? If your hospital sites have different
agreements please answer the below questions separately.
2. We appreciate some agreements span Acute, Community, Mental Health and Primary
Care Service providers. Which NHS organisations and/or hospital sites is this applicable
too?
3. When was it launched and when will it be up for renewal?
4. Who is the provider?
5. Across the full contract length, what is the value?
6. Can you share the procurement notice?
7. How many nurses were provided? If yes, what band and FTE?
8. Are their honorary contracts provided? If yes, what band and FTE?
9. What other incidentals were included in the tender? Including but not limited to; training,
IT, vehicles, grants, travel etc
10. What KPIs are included in the agreement and how is success measured?

Food Poisoning Admissions

I am requesting this information under the Freedom of Information Act.
1. How many hospital admissions in the past five years had the recorded reason for attendance of ‘food poisoning’? Please provide figures for the financial years 2020/21, 2021/22, 2022/23, 2023/24 and 2024/25.
Note: If it is not possible to provide a response for ‘food poisoning’ specifically, please include all admission codes under which a food poisoning-related admission could be logged.
2. How many reported admissions in total involved the following?:
2a. Salmonella
2b. E.Coli
2c. Campylobacter
For 2a, 2b and 2c, please also provide a breakdown by financial year (same years as in Q1)
If possible, please provide a breakdown of the foodstuffs stated as the cause of the illness.

Extended Reality (XR) in Healthcare

The University of Liverpool’s Civic Health Innovation Labs, as part of the Liverpool City Region’s Health and Life Science Innovation Zone, has commissioned a UK-wide landscape mapping study to better understand the current state of extended reality (XR) in healthcare. This research is being led by the XR Health Alliance, in collaboration with the University of Nottingham’s Mindtech, and will culminate in an interactive online report. This report aims to identify and showcase the breadth of XR-related research, development, and deployment across physical and mental health applications in the UK. It will serve as a valuable tool to help foster collaboration, shape future grant programmes, and support sector-wide growth and innovation.
The questions for this Freedom of Information request and further information can be found in the attached Word Document.

Safety Screening Forms prior to Imaging Examination

We would ask for your NHS Trust to provide information on two aspects:

1. Whether safety screening forms or checklists which are completed by patients prior to a diagnostic imaging examination are in paper form or in digital format (e.g. web-based or tablet)?
This includes but may not be limited to:
• Inclusive Pregnancy status (IPS) or last menstrual period (LMP) forms
• Magnetic resonance imaging (MRI) safety forms
• Contrast media administration (all modalities)
• Bone densitometry (DXA) patient questionnaire
• Any other examination-specific forms e.g. CT colonography or cardiac questionnaires.

2. If any of these are completed in paper form, we would ask for a copy of the current version to be sent via email.

We do not require information regarding staff completed forms e.g. WHO safety forms however, we would request that forms initially completed by a patient and co-signed by a staff member at the time of the examination are included.

The information is being sought to compare practice across Trusts.

Minor Injuries Wait

Clinical Activity Data, Health, Misc

I am writing to update and clarify my request for information under the Freedom of Information Act 2000.
The purpose of this request is to gather data on overnight Minor Injuries wait times within the trust.
Specifically, I am seeking anonymised data on the following:
1. How many patients in Minor Injuries waited 24 hours or more from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
2. How many patients in Minor Injuries waited for 3 hours or more between the hours of 11pm-6am from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
3. The average Minor Injuries wait time from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
If you are unable to provide the specified information:
• If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
• If you are unable to provide the specified information exactly as requested, please provide *any* data you have that is relevant to the request, e.g. 2024 only, and explain why the other information cannot be provided.

Referral Criteria for the Community Learning Disability Team

Clinical Activity Data, Data, Health, Misc

I am making a FOI request in respect of the referral criteria for the Community Learning Disability Team (CLDT), Gloucestershire.

Wound Care

I have attached a word document which has been laid out for ease. It clearly identifies what information I would like to receive from this freedom of information request.
By saving the attached word document file, it will allow you to fill in the boxes directly, alternatively, it can be printed off and filled in manually if that is easier.

Mental Health Patients who have Died from Diabetes Complications

Clinical Activity Data, Health, Misc

I would like to make a freedom of information request for the following:

The number of mentally unwell people in your care that have died from diabetes complications from 2014 – 2024. If you do not have these records then please direct me to the government department that does if possible.

Safeguarding

I would be very grateful for your time and support with providing the below information.

Information requested:

1. Does your Trust provide mental health services for:
o Adults (18+)?
o Children and adolescents (under 18)?

2. Please provide a brief overview of the services provided to Adults
3. Please provide a brief overview of services provided to Children

4. Please provide the number current number of employees

5. Please provide your organisations safeguarding team structure, including Executive, Named Dr’s, all statutory and non-statutory roles and admin support including:

Job titles (specifying adults and or children), MCA and Prevent etc
Please include Grade

Please can you kindly share
Whether the safeguarding function is managed centrally or across individual service areas
What the safeguarding team duties include
Do you provide Looked After Children services?
Is the LAC team part of the safeguarding team?

Who is the lead for implementing sexual safety? (job title and directorate)

Who is the lead for managing allegations against staff? (job title and directorate)

Who manages the child protection invites i.e. centrally, operational teams, safeguarding etc?

Data:

Please could you kindly share the following data

Safeguarding Adults

· Total number of Safeguarding Adult referrals made to the local authority per quarter from Q1 2024 through to Q4 2025
· Total number of referrals by Care Act category of abuse per quarter from Q1 2024 through to Q4 2025
· Total Number of Prevent Referral Q1 2024 through to Q4 2025
Total Number of Allegations against staff referred to the local authority between April 2024 to March 2025
Total Number of allegations against staff managed internally between April 2024 and March 2025

Safeguarding Children

· Safeguarding children referrals made to the local authority per quarter from Q1 2024 through to Q4 2025
· Referrals by Children Act category of abuse per quarter from Q1 2024 through to Q4 2025
· Total Number of Children Early Help referrals per quarter from Q1 2024 through to Q4 2025
· Total Number of Prevent Referrals Q1 2024 through to Q4 2025
Total Number of Allegations against staff referred to the LADO between April 2024 to March 2025
Total Number of allegations against staff managed internally between April 2024 and March 2025

Child Protection Engagement Data

· Total % of engagement (attendance or report) with Children protection Initial Case Conferences per Quarter Q1 2024 through to Q4 2025
Please clarify the % proportion of attendance per quarter
Please clarity the % proportion of reports send instead of attendance

· Total % of engagement with Review Child Protection Conferences per Quarter
Please clarify the % proportion of attendance per quarter
Please clarity the % proportion of reports send instead of attendance

Domestic Homicide Review, SAR’s and Rapid Reviews

Total Number of DHR’s which the organisation has contributed to April 2024 to March 2025
Themes of DHR’s in this time frame

Total Number of SAR’s which the organisation has contributed to April 2024 to March 2025
Themes of the SAR’s in this time frame

Total Number of Rapid Reviews which the organisation has contributed to April 2024 to March 2025
Themes of the RR in this time Frame

Training

Do you delivery DASH training? Are your trainers accredited?

Please provide training compliance as of Q4 2025 for the below:

Children Safeguarding Level 1
Children Safeguarding Level 2
Children Safeguarding Level 3
Adults Safeguarding Level 1
Adults Safeguarding Level 2
Adults Safeguarding Level 3
Prevent
MCA

Vegan Options at NHS

Eating Disorder, Health, Misc

I am writing to request information on vegan options. I request the information below under the Freedom of Information Act 2000.

Freedom of Information Request
1. Have you undertaken an equality impact assessment for vegans at the NHS? If yes, can you provide a copy of the assessment?

2. Are you following your public sector equality duty toward vegans? Please provide any documents or information to explain whether and how the PSED is being followed towards vegans.

3. Do you guarantee a full vegan option that is nutritionally appropriate on all NHS menus and cafeterias at all times, for all meals, including breakfast, lunch, dinner and snack options. By ‘guaranteed’ I mean, is there always a fully vegan option available.

For clarity, a salad without a plant-based protein and starch or carbohydrate would obviously not be nutritionally appropriate, nor would having only fruit or toast with jam available for a vegan person. For example, many vegetarian options adapted to be vegan would not be nutritionally appropriate as they would be lacking in protein unless there was a substitution provided.

4. Do you guarantee plant milk availability on all NHS campuses for coffee and tea? For clarity, plant milk refers to: Soy, oat, almond, or coconut milk.

Risk Assessment in Domestic Abuse

Health, MH Services, Misc

I am writing to request the following under the Freedom of Information Act, regarding use of and provision for the DASH checklist, aka Domestic Abuse, Stalking and Honour Based Violence

1. Is the DASH RIC used by your organisation as part of services (e.g. domestic abuse provision, victim support)?
2. Is the use of DASH RIC a standard provision or a requirement in contracts with third-party providers of relevant services (e.g. domestic abuse services, sheltered housing)?
3. If the DASH checklist is used by your organisation, which organisation or organisations provide the training that includes DASH training? (e.g. Domestic Abuse Matters training)
4. What is the cost to your organisation of such training? Please break this down by financial year over the last five years, as well as by organisation (if more than one organisation provides the relevant training)

Treatment of Bruxism

Please provide the following information, Any and all annual data on record to the present day.

1. How many patients have been referred to the trust and presented for the treatment of BRUXISM (Grinding of the teeth)?

2. Please provide geographical date in regards which hospital the patients presented to.

3. Annual cost to the trust and its subsidiaries.

NHS Patients SARC

I wish to make a freedom of information request and would be grateful if you could provide the following information within 20 working days:

a) The number of staff employed at your Trust’s Sexual Assault Referral Centre (SARC) for the years 2010 – 2024.

b) The number of children aged under 18 years old who have been received support by your Trust’s SARC between the years 2010 – 2024 and, if possible, the number of these who are identified as having been victims of gang-based CSE.

c) The number of victims of CSE who received mental health support from your trust between 2018 and 2024.

d) The number of children identified by your Trust as requiring safeguarding measures as a result of CSE between the years 2010 and 2024.

This should not exceed any cost limits you may have but should you, for whatever reason, decide that it does, the please proceed with parts a – c.

Spiritual, religious and/or chaplaincy services

Health, HR

As part of a piece of work I am undertaking to review the spiritual, religious, and / or chaplaincy services offered by NHS England, I am contacting you to ask for the following information to please be provided.

1. How many whole-time equivalents are employed in the spiritual, religious, and / or chaplaincy service(s) and what are their bandings? Please differentiate between staff on substantive and temporary contracts, as well as staff working in the service on bank or agency contracts.

2. What are the typical core hours of the spiritual, religious, and / or chaplaincy service(s) on offer? How are these service(s) provided over the week (i.e. weekdays only, seven days a week, etc)?

3. What type of support (such as regular activities, events, or gatherings) is offered by the spiritual, religious, and / or chaplaincy service(s)? Please differentiate this between support offered to patients, support offered to family / friends, and support offered to staff members.

4. What on-call or out-of-hours provisions are made by the spiritual, religious, and / or chaplaincy service(s) at your Trust? Please differentiate between provisions offered by staff members employed by the Trust, and provisions offered by external contractors / arrangements.

5. What support is offered to the spiritual, religious, and / or chaplaincy services(s) by external organisations? For instance, what contracts are held by the Trust for this / these service(s) and who are these contracts with?

6. On average, how many service users are supported by the spiritual, religious, and / or chaplaincy service(s) in a week? Please take an average of service users supported between January and December 2024.

7. What is the overall satisfaction for the spiritual, religious, and / or chaplaincy service(s) offered by your Trust? Please provide the overall satisfaction for the period January 2024 to December 2024.

8. What supervision, if any, is provided to staff working in the spiritual, religious, and / or chaplaincy service(s)? Please identify whether this is provided by your Trust or by an external provider, and the average annual cost for this provision.

9. Please provide a contact name and contact email address if there should be any additional queries relating to this Freedom of Information request.

Pancreatic Enzyme Replacement Therapy

(1) Has your Trust procured any pancreatic enzyme replacement therapy (PERT) products from overseas suppliers between January 2023 and present? Please respond with yes or no. If yes, please answer the following: (a) Which countries were these products sourced from? (b) How many ‘special order’ prescriptions for these products have been dispensed? (c) What percentage of the local demand has been covered by these overseas products?

Dravet Syndrome/Lennox-Gastaut Syndrome

I would like to submit an FOI request for the following data for Gloucestershire Health and Care NHS Foundation Trust:
• The number of patients treated for Dravet syndrome in 2024, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The number of patients treated for Dravet syndrome in 2025, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The number of patients treated for Lennox-Gastaut syndrome in 2024, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The number of patients treated for Lennox-Gastaut syndrome in 2025, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The above data separated by treatment, focusing on the following treatments:
o fenfluramine
o sodium valproate
o stiripentol
o clobazam
o cannabidiol
o levetiracetam
o topiramate
o potassium bromide
o Other treatments
 carbamazepine
 gabapentin
 lacosamide
 lamotrigine
 oxcarbazepine
 phenobarbital
 pregabalin
 tiagabine
 vigabatrin
 rufinamide
• Numbers of patients moving from one specific treatment to another e.g. fenfluramide gains from cannabidiol, sodium valproate losses to cannabidiol
• Alternatively, just the numbers of patients on each treatment for each month/quarter will be able to show how the numbers on each treatment are changing

Insourcing for Pathology Services

Health, Procurement

Under the Freedom of Information Act 2000, I request the following information regarding your use of insourcing for haematology, histopathology, and/or microbiology services between 1 April 2024 and the date of this request (i.e., the last 12 months):

Service Usage:

Does your trust currently use (or has it used in the last 12 months) insourcing providers for any of the following services?

a) Haematology
b) Histopathology
c) Microbiology
d) Oncology
(If yes, please specify which specialties)

Provider Details:

For each insourced specialty above, provide:
a) The name(s) of the external provider(s).
b) The start and end date(s) of the contract(s).

Scope & Volume:

A brief description of the services covered (e.g., “blood film reporting,” “biopsy analysis,” “infection screening”).

Estimated annual spend (or total spend) on these insourcing arrangements for 2023/24.

Procurement Method:
Was the contract awarded via a framework (e.g., NHS SBS DPS, Crown Commercial Service)? If yes, state which one.

If no insourcing is used for these specialties, please state “None.”

Adherence to NHS Guidance on Overactive Bladder Treatment

Under the Freedom of Information Act 2000, I would be grateful if you could provide the following information:
1. Adherence to National Guidelines
Does your Trust currently follow any of the following national guidelines for the treatment and management of Overactive Bladder (OAB)? Please indicate “Yes” or “No” for each of the following:
a) NICE Interventional Procedure Guidance on sacral nerve stimulation for urge incontinence and urgency-frequency (IPG64)
b) NICE Clinical Guideline on Urinary Incontinence in Women (CG171)
c) NICE Clinical Guideline on Lower Urinary Tract Symptoms in Men (CG97)
d) Any NHS England-issued clinical guidelines related to OAB management
2. Locally Adopted Guidelines
For any of the above guidelines that your Trust follows, please provide the title, version number, and date of the current guidance or policy document in use.
3. Local Protocols or Deviations
If your Trust does not follow one or more of the national guidelines listed above, or has developed local clinical pathways or protocols for the management of OAB, please provide a copy of the relevant local policy or a summary of the key differences compared to national guidance.

Cancer Treatment

Under the Freedom of Information Act 2000, I would like to request the following information:
1. For each of the last five years (or as many years as data is available), please provide:
o The total number of patients recorded on the urgent referral cancer treatment pathway.
o The number of these patients whose waiting time was stopped due to an enabling treatment, as defined in the National Cancer Waiting Times Monitoring Dataset Guidance.
2. If available without exceeding cost limits, please also provide a breakdown by:
o Type of enabling treatment used (e.g., stent, dental treatment, or any others as set out in National Cancer Waiting Times Monitoring Dataset Guidance)

Infection Control Leads

Please can you provide the following:

By site location(s) within the trust:

Do you have a Decontamination Lead(s)?
What is their name(s), and what is their NHS email address?

Do you have an Infection Control Lead(s)?
What is their name(s), and what is their NHS email address?

Do you have a Sterile Services Manager(s)?
What is their name(s), and what is their NHS email address?

Do you have an Endoscopy Decontamination Manager(s)?
What is their name(s), and what is their NHS email address?

Do you have an Estates Manager(s) in charge of Decontamination Equipment Validation?
What is their name(s), and what is their NHS email address?

Chronic Pain Waiting List

I am submitting this request, on behalf of myself, under the Freedom of Information Act and the Code of Practice on Openness in the NHS. Please confirm the Trust holds the following data, and where it is held please provide the data. Please use the attached spreadsheet if possible.

1. Does your trust provide a chronic pain service? (Yes/No)
If no, this is the end of our request.

If yes, and the service is consultant-led, please provide:
2. Please confirm that the Trust submits RTT data for this service (yes/no)
3. Please confirm that the Trust submits WLMDS data for this service (yes/no)
4. Please supply the Trust’s RTT submission for every month between April 2024 and April 2025 (inclusive), but please only show data for TFC 191 – Pain Management. This data is available in the public domain but it is supplied aggregated with other specialities in category: ‘X02 – Other – Medical Services’. We are requesting it be disaggregated from this category. Please share this in the format that you have it.
5. Only if the data requested in #4 is unavailable, please provide the data requested in 5a-e for every month between April 2024 and April 2025:
5a. The number of people on the waiting list, as of the first day of the month
5b. The average waiting time in weeks
5c. The distribution of waiting times, as of the first day of the month (see suggested breakdown in the attached spreadsheet)
5d. Number of clock starts during the month
5e. Number of clock stops during the month for treatment, broken down by reason
5f. Number of clock stops during the month for non-treatment, broken down by reason
6. The average time between clock start and an interventional pain procedure being performed, in weeks
7. Please provide the Trust definitions used for Pain Management services for:
7a. Clock starts (e.g. referral received, referral received and validated, etc.)
7b. Clock stops for treatment (e.g. first appointment, advice given, information provided, etc.)
7c. Clock stops for non-treatment (please provide breakdown)

If yes, and the service is not consultant-led, please provide:
8. What is the clinician’s role who holds overall clinical responsibility, including governance, outcomes and quality, for the service (e.g. specialist nurse, clinical psychologist, other)? We are requesting the person’s position rather than any personal information.
9. Does the service provide interventional pain procedures, such as injections? (Yes/No)
9a. If yes, please provide the clinician’s role that performs them (e.g. consultant in pain medicine)? We are requesting the person’s position rather than any personal information.
9b. If no, where do you refer patients requiring interventional pain procedures to?
10. Please provide the following data for the non-consultant-led Pain Management service for every month between April 2024 and April 2025 (inclusive):
10a. The number of people on the waiting list at the first day of the month
10b. The average waiting time in weeks
10c. The distribution of waiting times, as of the first day of the month (see suggested breakdown in the attached spreadsheet)
10d. The number of new referrals during the month
10e. The number of patients who started treatment during the month (i.e. had their first appointment)
10f. The number of patients discharged without treatment (i.e. rejected referrals)

Maternity Care

Under the Freedom of Information Act 2000, I would like to request the following information relating to maternity care provided by your Trust.

I am conducting research into potential disparities in pain relief experienced by patients of different ethnic backgrounds during childbirth and maternity care. Specifically, I would like to request the following:

a) Does your Trust provide any mandatory training to maternity staff on cultural competence, anti-racism, or unconscious bias, particularly relating to patient care or pain management?

b) If so, please provide: · The name(s) of the training programme(s) used · Which organisation provides the training · Whether completion is mandatory · When it was introduced

I understand that not all data may be held in the exact format requested. However, I would be grateful for any partial or relevant information you can provide. If any part of this request exceeds the cost limit, please inform me as soon as possible so that I can refine the request.

Audiology

I am contacting you with a FoI request for the benefit of RNID.

Please can you provide the name and contact details for the current Head of Adult Audiology for Gloucestershire Health and care NHS foundation trust.

If this role does not exist in your Trust, please provide the name and contact details for the most senior member of staff responsible for audiology services.

Food Poisoning due to Consuming Wild Food

I would like to submit a request for information under the Freedom of Information Act 2000 (FOIA) regarding cases of food poisoning due to incorrect identification or inappropriate preparation of wild food.

Please provide the relevant information for the period between 1 April 2020 and the most recent date for which data is available. Please could you provide the following:

A yearly breakdown of the number of cases of food poisoning due to incorrect identification or inappropriate preparation of wild food.
The type of wild food that caused the food poisoning (for example: fungi, plant, berries, etc…). Please include the specific species if known.
The symptoms experienced by the patient and the recovery time (for example: overnight stay or discharged within a couple hours)
The location where this food was picked. We would define ‘wild or foraged’ foods to be either: Wild, naturally growing food which was picked and consumed by an individual Wild, naturally growing food which was consumed by an individual, but was served in a restaurant environment, having been picked in the wild within the UK.

If you need to carry out a key terms search to locate these records, please include the terms “foraged”, “foraging”, “wild food”, “forager”, “wild ingredients”. If you would document these cases in another way, please include these results as per the spirit of my request.

If you feel that my request is unclear or too broad, I would be grateful if you could provide me with some guidance as to how I could refine it.

Exceptions for Routine Treatment Implants

I understand that whilst the Sexual Health team do not provide routine treatment regarding certain implants, exceptions may be made for certain groups. Please could you share a copy of the exceptions list / exceptions policy?

Wheelchair Services: Open Caseloads and Waiting Times

As you will be aware, the recently released Wheelchair Alliance report has highlighted the postcode lottery experienced by wheelchair users, and the many long waits. I am interested in the underlying data.

Please provide the following information separately for each of the wheelchair services in your area. This data is ‘essential’ or ‘basic’ information relating to each referral and should be easily extracted from the relevant Case Management System, Electronic Patient Record, or similar. Please feel free to provide the data in alternative formats, e.g. an Excel spreadsheet, if appropriate.

1a) How many open referrals does the service have for ADULTS?
1b) Of those open referrals, how many have been open for LESS than 18 weeks?
1c) Of those open referrals, how many have open for MORE than 18 weeks?
1d) Of those open referrals, how many have been open for MORE than 52 weeks?
1e) Of those open referrals, how many are ‘low need’ (per NHS Wheelchair Data Collection definition)?
1f) Of those open referrals, how many are ‘medium need’?
1g) Of those open referrals, how many are ‘high need’?
1h) Of those open referrals, how many are ‘specialist need’?
1i) Of those open referrals, how many are for powered wheelchairs?

2a) How many open referrals does the service have for CHILDREN/YOUNG PEOPLE?
2b) Of those open referrals, how many have been open for LESS than 18 weeks?
2c) Of those open referrals, how many have open for MORE than 18 weeks?
2d) Of those open referrals, how many have been open for MORE than 52 weeks?
2e) Of those open referrals, how many are ‘low need’ (per NHS Wheelchair Data Collection definition)?
2f) Of those open referrals, how many are ‘medium need’?
2g) Of those open referrals, how many are ‘high need’?
2h) Of those open referrals, how many are ‘specialist need’?
2i) Of those open referrals, how many are for powered wheelchairs?

Administering of Injections

Health, Pharmacy

I am writing to request information under the Freedom of Information Act 2000 regarding the administration of injections to patients without their consent within the Trust.

Specifically, I request the following information for the period 1 January 2020 – 15 March 2025:
1. The total number of times patients were administered injections without their consent and the date of any such cases.
2. A breakdown of the medications administered (e.g., antipsychotics, sedatives) in these cases.
3. The legal authority under which these injections were administered.
4. The number of incidents where rapid tranquilization was used and the date of any such cases.
5. Any policy documents or guidelines used by the Trust regarding the administration of injections without consent.

If any part of this request exceeds the cost limit under the FOI Act, I would appreciate advice on how I may refine my request to stay within the limit.

Use of Processed Meats Containing Nitrates or Nitrites in Meals

I am writing to make a request for information under the Freedom of Information Act 2000.

I would like to request the following information regarding the use of processed meats containing nitrates or nitrites in meals provided by your authority.

1. Does your organisation procure or serve processed meat (such as bacon, ham, sausages, or other cured meats) that contain nitrates or nitrites as preservatives?

2. If so, please provide details of the types of processed meat served and any guidance or policies in place regarding their procurement.

NHS Treatment of Botched Overseas Surgeries

I am submitting this request under the Freedom of Information Act 2000 to obtain data on NHS treatment of complications arising from surgical procedures performed overseas.

Request Details

1. NHS Admissions for Complications Following Overseas Surgeries
• The total number of hospital admissions where the NHS has treated patients for complications resulting from surgeries conducted abroad.
• A yearly breakdown from January 2020 to January 2025 (or the most recent available period).

2. Breakdown of Patients Treated
For each year, please provide where available:
• Age group of patients (e.g.: under 18, 18-24, 25-34, 35-44, 45-54, 55-64, 65+).
• Gender of patients.

3. Data Classified Under Relevant ICD-10 Codes (or their NHS equivalents):
Please provide a breakdown of cases recorded under the following ICD-10 codes related to complications of surgical procedures:
• T81 – Complications of procedures (e.g., infections, wound disruption, foreign bodies left in the body).
• T82-T85 – Complications of prosthetic devices, implants, and grafts.
• T86 – Failure and rejection of transplanted organs and tissues.
• T87 – Complications of amputations and reattachments.
• T88 – Other complications of surgical and medical care (including anaesthesia-related complications).
• Y60-Y69 – Surgical errors and misadventures (e.g., accidental punctures, foreign objects left inside patients, failure of sterile precautions, inappropriate procedures).
• Y70-Y79 – Medical devices associated with adverse incidents.
• Y83-Y84 – Abnormal patient reactions or complications following surgery or other medical procedures.

4. Specific Details on Procedures Leading to NHS Admissions
Where available, please provide:
• The type of surgery the patient originally underwent abroad (e.g., cosmetic surgery, weight loss surgery, orthopaedic surgery, dental work, etc.).
• The intended purpose of the surgery (e.g., aesthetic enhancement, weight loss, joint replacement, reconstructive surgery, etc.).
• The type of complication requiring NHS intervention (e.g., infection, implant failure, excessive bleeding, wound breakdown, nerve damage, sepsis).

5. NHS Cost of Treating Complications from Overseas Surgeries
• The total annual cost incurred by the NHS in treating complications from overseas surgeries.
• If available, an estimated breakdown of costs by procedure type.

High Acuity Monitoring

We would like to place a Freedom of Information request, wishing to obtain an Install Base report for Monitoring systems within high acuity areas at your NHS hospitals.

Additional Questions

• How many anaesthetic rooms do you have in Theatres?
• How many theatre rooms do you have?
• Do you have a telemetry system for coronary care?
• How many telemetry systems do you have?

Analysis on the Uptake of Biosimilar Use for Ustekinumab

I am conducting an analysis on the uptake of biosimilar use for Ustekinumab.

I would be grateful if you could please tell me how many patients were treated with Ustekinumab (for any disease) for the three-month period specified within the questions.

Q1 – How many patients were treated with Ustekinumab and its biosimilars (for any disease) from the start of October 2024 to the end of December 2024?
Please use the latest available 3 months if October to December is not available and specify which 3 months have been used.

Q2 – How many patients were treated with Stelara and its biosimilars (for any disease) in the months October 2024, November 2024, and December 2024?
Please use the latest available 3 months if October to December is not available and specify which 3 months have been used.

Ophthalmology IT Systems and Imaging Capabilities

Health, IT

Under the Freedom of Information Act 2000, I would like to request the following information regarding the ophthalmology services and IT systems used within your Trust:

Ophthalmology Department & IT Record System
1. Does your Trust have an ophthalmology department and/or provide ophthalmology clinics?
2. If so, what is the name of the principal IT record system used to document results from patient consultations within ophthalmology?

Imaging Capabilities & System Integration
3. Does the principal IT system allow clinicians to view images from scans conducted during a clinic visit?
4. Are there any types of medical images that cannot be imported into this principal IT system? If so:
• What is the name of the IT programme used by clinicians to view these images?
• What is the name of the scan/modality that generates these images?

Data Integration with National Systems
5. Does the principal IT system integrate with the NHS Spine or other national patient record systems (e.g., OpenEyes, Medisoft, Epic)?
6. Does the system support the exchange of structured data with other NHS Trusts or external healthcare providers?

Patient Access & Communication
7. Does the system allow patients to access their ophthalmology records, including images, via the NHS App or another patient portal?
8. Are there any restrictions on how imaging data can be shared with patients and external providers?

Image Storage & Viewing Capabilities
9. What is the storage capacity and retention policy for ophthalmology-related imaging within the IT system?
10. If images are not viewable within the principal IT system, does the Trust use a separate PACS (Picture Archiving and Communication System) for ophthalmology imaging?

Future IT Developments & Interoperability
11. Is the Trust planning any upgrades or changes to its ophthalmology IT infrastructure in the next five years?
12. Are there known interoperability challenges that affect the transfer of ophthalmology data within the Trust or between NHS organizations?

The Primary Care-Associated Helicobacter Pylori testing

This FOI request seeks to establish the types, numbers, costs and timings of Helicobacter pylori tests performed by your Trust (or on its behalf) for primary care providers.

Question 1: Your Trust
In your response to this FOI request, could you please specify the identity of the parts of your Trust for which this FOI is relevant, and for which you are responding.

Question 2: Types of Tests and Providers Which types of tests relevant for the primary care diagnosis of Helicobacter pylori (e.g., stool antigen test, urea breath test, serology) do you perform within your Trust, or have performed on your behalf by a Third party? If outsourced, could you please specify the Third party used.

Question 3: Test Types and Volumes
How many Helicobacter pylori tests of each of these types were performed by your Trust or on its behalf in the most recent 12-month period, or other defined accounting period for which data is available?

Question 4: Requirements for in-Person Testing Which types of tests required the in-person attendance of the patient at your Trust or its Third-party provider for testing, how many such in-person attendances were required, and what was the average time taken between patient arrival and departure?

Question 5: Turnaround Time for Test Results Specifying each type of Helicobacter pylori test performed by your Trust, or on its behalf, could you please provide the average time (in hours) between receipt of sample to transmission of test result to the GP practice?

Question 6: Test costs and Tariffs
For each type of Helicobacter pylori test performed by your Trust or on its behalf, what is the total cost of performing the test to your Trust or the Third party provider (i.e., personnel, infrastructure, reagents and consumables, etc)? What does your Trust charge for performing each of these tests? Do these tests correspond to standard NHS tariffs or HRG codes? If so, could you please specify the tariff code and amount charged for each test type.

Provision of Vestibular Assessment and Rehabilitation

I would like to make a Freedom of Information request regarding the provision of vestibular assessment and rehabilitation by your Trust’s Falls Prevention Service (or equivalent).
World Guidelines for Falls Prevention and Management for Older Adults: A Global Initiative published in September 2022 (see below link) recommend routinely asking about dizziness and undertaking follow up assessment to identify causes, including vestibular. They reference the high incidence of BPPV and vestibular dysfunction in those presenting with falls and suggest managing vestibular issues should be considered as part of a multifactorial approach.
World Guidelines for Falls Prevention and Management for Older Adults: A Global Initiative | British Geriatrics Society (bgs.org.uk)

The request therefore has 3 specific questions:
1. Does your falls prevention team (or equivalent) have staff trained to assess and treat vestibular dysfunction?
2. If so, from which profession(s)?
3. Do you have any plans to develop this part of your falls prevention service?

Mental Health Patient Homicides

FOI request: Mental health patient homicides at Gloucester Health and Care NHS Foundation Trust and independent investigations

1. Please disclose since 1994, how many homicides by trust patients have occurred within a year of contact with the trust (and its predecessor bodies).

Please give a breakdown by year.

2. How many of these patient homicides were reported to NHS England or its predecessor bodies?

Please give a breakdown by year.

3. How many of the patient homicides reported to NHS England were independently investigated under HSG 94-27?

If not all patient homicides were reported to NHS England and/or its predecessor bodies, can the trust explain why this was so?

Early Intervention in Psychosis

Dear Gloucestershire Health and Care NHS Foundation Trust,

This is a request for information under the Freedom of Information Act 2000. I would like to request the following information:

1. The number of patients treated year-on-year by the Early Intervention in Psychosis team of Gloucestershire Health and Care NHS Foundation Trust in:
a. 2020/21
b. 2021/22
c. 2022/23
d. 2023/24
2. The number of staff that work in the Early Intervention in Psychosis team of Gloucestershire Health and Care NHS Foundation Trust in:
a. 2020/21
b. 2021/22
c. 2022/23
d. 2023/24
3. The percentage increase/decrease in the budget for the Early Intervention in Psychosis team of Gloucestershire Health and Care NHS Foundation Trust in:
a. 2020/21
b. 2021/22
c. 2022/23
d. 2023/24
4. What was the mean waiting time for EIP patients between first referral and starting treatment in:
a. 2020/21
b. 2021/22
c. 2022/23
d. 2023/24
5. What was the longest waiting time for an EIP patient on your caseload between first referral and starting treatment in:
a. 2020/21
b. 2021/22
c. 2022/23
d. 2023/24

B&B Accommodation for Discharged Mental Health Patients